CD4 and neoplasm: This suggests that CFRI-mediated PTT evidently promotes the differentiation of immature T cells into CD4+ and CD8+ T cells, enhancing immune surveillance and tumor elimination and potentially preventing tumor progression, recurrence, or metastasis.